首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice
【2h】

Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice

机译:腺相关病毒传递的单纯疱疹病毒胸苷激酶基因的组织特异性表达抑制无胸腺小鼠肝细胞癌的生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

About 70% of hepatocellular carcinomas are known to express α-fetoprotein, which is normally expressed in fetal but not in adult livers. To induce herpes simplex virus-thymidine kinase expression in these cancer cells, we constructed an adeno-associated viral vector containing the HSV-TK gene under the control of the α-fetoprotein enhancer and albumin promoter. We previously demonstrated in vitro that although this vector can transduce a variety of human cells, only transduced AFP and albumin-expressing hepatocellular carcinoma cell lines were sensitive to killing by ganciclovir (GCV). In the present study, we explored the effect of this vector on hepatocellular carcinoma cells in vivo. Subcutaneous tumors generated in nude mice by implanting hepatocellular carcinoma cells previously transduced with this vector shrank dramatically after treatment with GCV. Bystander effect was also observed on the tumors generated by mixing transduced and untransduced cells. To test whether the tumor cells can be transduced by the virus in vivo, we injected the recombinant adeno-associated virus into tumors generated by untransduced hepatocarcinoma cell line. Tumor growth were retarded after treatment with GCV. These experiments demonstrate the feasibility of in vivo transduction of tumor cell with rAAV.
机译:已知约70%的肝细胞癌表达α-甲胎蛋白,通常在胎儿中表达,但在成年肝脏中不表达。为了在这些癌细胞中诱导单纯疱疹病毒胸苷激酶的表达,我们构建了一个腺相关病毒载体,该载体包含在甲胎蛋白增强子和白蛋白启动子控制下的HSV-TK基因。我们以前在体外证明,尽管该载体可以转导多种人类细胞,但只有转导的AFP和表达白蛋白的肝癌细胞系对更昔洛韦(GCV)的杀伤敏感。在本研究中,我们探讨了该载体在体内对肝癌细胞的作用。在用GCV治疗后,通过植入先前用该载体转导的肝癌细胞在裸鼠体内产生的皮下肿瘤急剧缩小。在通过混合转导和未转导的细胞而产生的肿瘤上也观察到旁观者效应。为了测试是否可以在体内通过病毒转导肿瘤细胞,我们将重组腺相关病毒注射到未转导的肝癌细胞系产生的肿瘤中。用GCV治疗后,肿瘤生长受阻。这些实验证明了用rAAV体内转导肿瘤细胞的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号